Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 2

Conditions

Obesity 4Sexual Infantilism 3Polycystic Ovary Syndrome 2Craniopharyngioma 2Weight Loss 1Overweight 1Fatty Liver 1Diabetes Mellitus, Type 1 1

Interventions

Metformin 14Clomiphene 6Progesterone 5Chorionic Gonadotropin 5drospirenone and ethinyl estradiol combination 4Sugars 4Letrozole 4Flutamide 4Estrogens 4Cholecalciferol 4follitropin alfa 3Pioglitazone 3Medroxyprogesterone Acetate 3Glycoprotein Hormones, alpha Subunit 3Estradiol 3Vitamin D 2Testosterone 2Resistance Training 2Raloxifene Hydrochloride 2Ovidrel 2Liraglutide 2Leuprolide 2Glucose Tolerance Test 2Exenatide 2Ethinyl Estradiol 2Contraceptives, Oral 2Continuous Positive Airway Pressure 2saxagliptin 1salicylsalicylic acid 1penclomedine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Has results × Polycystic Ovary Syndrome × Exenatide × Clear all
NCT02157974 2024-06-04

APPLE

University of Colorado, Denver

Phase 2/3 Completed
92 enrolled 17 charts
Other

Fatty Liver, Obesity, Polycystic Ovary Syndrome

NCT02635386 2021-01-29

EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)

Woman's

Phase 3 Completed
119 enrolled 34 charts
Other

Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡